^
EGFR expression
Lung Non-Small Cell Squamous Cancer
necitumumab
Sensitive
:
A1
No biomarker
Lung Non-Small Cell Squamous Cancer
pembrolizumab
Sensitive
:
A1
No biomarker
Lung Non-Small Cell Squamous Cancer
afatinib
Sensitive
:
A1
No biomarker
Lung Non-Small Cell Squamous Cancer
tislelizumab
Sensitive
:
A1
No biomarker
Lung Non-Small Cell Squamous Cancer
nivolumab
Sensitive
:
A2
No biomarker
Lung Non-Small Cell Squamous Cancer
bevacizumab
Resistant
:
A2
PD-L1 expression
Lung Non-Small Cell Squamous Cancer
nivolumab + ipilimumab
Sensitive
:
A2
No biomarker
Lung Non-Small Cell Squamous Cancer
paclitaxel
Sensitive
:
A2
No biomarker
Lung Non-Small Cell Squamous Cancer
gemcitabine
Sensitive
:
A2
No biomarker
Lung Non-Small Cell Squamous Cancer
docetaxel
Sensitive
:
A2
No biomarker
Lung Non-Small Cell Squamous Cancer
carboplatin + albumin-bound paclitaxel
Sensitive
:
A2
No biomarker
Lung Non-Small Cell Squamous Cancer
albumin-bound paclitaxel
Sensitive
:
A2
No biomarker
Lung Non-Small Cell Squamous Cancer
nivolumab + ipilimumab
Sensitive
:
A2
No biomarker
Lung Non-Small Cell Squamous Cancer
EP
Sensitive
:
A2
No biomarker
Lung Non-Small Cell Squamous Cancer
GC
Sensitive
:
A2
No biomarker
Lung Non-Small Cell Squamous Cancer
CP
Sensitive
:
A2
No biomarker
Lung Non-Small Cell Squamous Cancer
CaT
Sensitive
:
A2
PD-L1 overexpression
Lung Non-Small Cell Squamous Cancer
atezolizumab
Sensitive
:
A2
PD-L1 expression
Lung Non-Small Cell Squamous Cancer
pembrolizumab
Sensitive
:
A2
PD-L1 overexpression
Lung Non-Small Cell Squamous Cancer
pembrolizumab
Sensitive
:
A2
PD-L1 overexpression
Lung Non-Small Cell Squamous Cancer
nivolumab + ipilimumab
Sensitive
:
A2
PD-L1 overexpression
Lung Non-Small Cell Squamous Cancer
cemiplimab
Sensitive
:
A2
No biomarker
Lung Non-Small Cell Squamous Cancer
carboplatin + docetaxel
Sensitive
:
A2
No biomarker
Lung Non-Small Cell Squamous Cancer
GemVin
Sensitive
:
A2
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our